West Oak Capital, LLC Astrazeneca PLC Transaction History
West Oak Capital, LLC
- $2.52 Billion
- Q3 2025
A detailed history of West Oak Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, West Oak Capital, LLC holds 175 shares of AZN stock, worth $15,645. This represents 0.01% of its overall portfolio holdings.
Number of Shares
175
Previous 175
-0.0%
Holding current value
$15,645
Previous $122,000
9.84%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,554Shares Held
503MCall Options Held
5.54MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...